Clarus Therapeutics Holdings Inc.'s ability to collect accounts receivable sequentially worsen to 2.26, indicating more challenging environment then in the first quarter 2022, but still, it is a far cry from any concerns. Clarus Therapeutics Holdings's Accounts Receivable average collection period in the Jun 30 2022 quarter, has increased to 162 days, from 124 days, in the Mar 31 2022 quarter.

If we take a look into Healthcare sector 626 other companies have achieved higher receivables turnover ratio. While total ranking has deteriorated relative to the period ending Jun 30 2022 from 0 to 3797.

What is Receivable Turnover Ratio?
What is Clarus Therapeutics Holdings Inc. Selling?

What is Receivable Turnover Ratio?

Select the Comparisons :

None ▼

Select the Ratio:

Accounts Receivables Turnover▼

None ▼

Accounts Receivables Turnover▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

CRXT Receivables Turnover Ratio	(Jun 30 2022) II. Quarter	(Mar 31 2022) I. Quarter	(Dec 31 2021) IV. Quarter	(Sep 30 2021) III. Quarter	(Jun 30 2021) II. Quarter
Y / Y Receivable Change	-	-	44.11 %	-	-
Y / Y Revenue Change	45.74 %	72.15 %	10.06 %	92.72 %	-
Receivable Turnover Ratio (TTM)	2.26	2.94	4.21	4.78	10.43
CRXT's Total Ranking	# 3797	# 0	# 0	# 0	# 0
Accounts Receivable average collection period days	162	124	87	76	35
Seq. Receivable Change	8.74 %	26.24 %	-8.53 %	-	-
Seq. Revenue Change	0.97 %	-12.08 %	6.44 %	54.23 %	19.27 %

Receivable Turnover Company Ranking
Within:	No.
Biotechnology & Pharmaceuticals Industry	# 68
Healthcare Sector	# 627
Overall Market	# 3797

Receivable Turnover Ratio Statistics
High	Average	Low
1.08	1.08	1.08
(Jun 30 2022)

CRXT Company Profile • Back to CRXT Efficiency Comparisons • Compare CRXT Receivables Turnover Ratio to its Competitors

Financial Statements
Clarus Therapeutics Holdings's Accounts Receivable	$ 9 Millions	Visit CRXT's Balance sheet
Clarus Therapeutics Holdings's Sales TTM	$ 17 Millions	Visit CRXT's Income Statement
Sources of CRXT's Revenues		Visit CRXT's Sales by Geography

Other Accounts Receivable Turnover Ratios
Biotechnology & Pharmaceuticals Industry Accounts Receivable Turnover Trends and Statistics
Healthcare Sector Accounts Receivable Turnover Statistics
Accounts Receivables Turnover Trends for overall market
CRXT's Receivable Turnover Ratio versus Biotechnology & Pharmaceuticals Industry, Healthcare Sector and total Market
Highest Ranking Accounts Receivables Turnover
Lowest Ranking Accounts Receivables Turnover

You may also want to know
CRXT's Growth Rates	CRXT's Roa	CRXT's Inventory Turnover Ratio	CRXT's Dividend Comparisons
CRXT's Profitability Ratios	CRXT's Roi	CRXT's Asset Turnover Ratio	CRXT's Dividend Growth
CRXT's Valuation Ratios	CRXT's Roe	CRXT's Financial Strength Ratios	CRXT's Dividend Payout Ratio

Companies with similar Receivables Turnover Ratio for the quarter ending Jun 30 2022, within Healthcare Sector	Receivable Turnover Ratio	Revenues for 12 Months ending Jun 30 2022	Receivable at quarter ending Jun 30 2022
Endo International Plc	5.32	$ 2,782.830 Millions	$ 522.658 Millions
Streamex Corp	5.28	$ 0.132 Millions	$ 0.025 Millions
Todos Medical Ltd	5.27	$ 9.845 Millions	$ 1.867 Millions
Zynex inc	5.27	$ 142.995 Millions	$ 27.134 Millions
Revvity Inc	5.26	$ 4,683.605 Millions	$ 889.889 Millions
Amgen Inc	5.26	$ 26,384.000 Millions	$ 5,016.000 Millions
Siga Technologies Inc	5.25	$ 147.410 Millions	$ 28.103 Millions
Guided Therapeutics Inc	5.24	$ 0.089 Millions	$ 0.017 Millions
Guardion Health Sciences Inc	5.21	$ 10.272 Millions	$ 1.970 Millions
Catalent Inc	5.21	$ 4,802.000 Millions	$ 921.250 Millions
Bristol myers Squibb Company	5.21	$ 47,144.000 Millions	$ 9,044.750 Millions
Establishment Labs Holdings Inc	5.20	$ 143.994 Millions	$ 27.708 Millions
Lantheus Holdings Inc	5.18	$ 664.238 Millions	$ 128.181 Millions
Ptc Therapeutics inc	5.11	$ 618.236 Millions	$ 121.083 Millions
Orasure Technologies Inc	5.11	$ 265.423 Millions	$ 51.989 Millions
Bionano Genomics Inc	5.10	$ 23.323 Millions	$ 4.574 Millions
Elanco Animal Health Incorporated	5.10	$ 4,646.000 Millions	$ 911.500 Millions
Y mabs Therapeutics inc	5.06	$ 39.846 Millions	$ 7.877 Millions
Xencor Inc	5.05	$ 289.369 Millions	$ 57.354 Millions
Cyclo Therapeutics Inc	5.02	$ 1.726 Millions	$ 0.344 Millions
Caredx Inc	5.01	$ 314.859 Millions	$ 62.851 Millions
Acutus Medical Inc	4.99	$ 16.720 Millions	$ 3.349 Millions
Deciphera Pharmaceuticals Inc	4.98	$ 109.136 Millions	$ 21.911 Millions
Dexcom Inc	4.98	$ 2,673.400 Millions	$ 537.175 Millions
Agilon Health Inc	4.95	$ 2,245.078 Millions	$ 453.852 Millions
Isoplexis Corporation	4.93	$ 18.495 Millions	$ 3.754 Millions
Sarepta Therapeutics Inc	4.88	$ 835.184 Millions	$ 171.206 Millions
Cvrx inc	4.88	$ 16.160 Millions	$ 3.314 Millions
Ginkgo Bioworks Holdings Inc	4.87	$ 626.860 Millions	$ 128.775 Millions
Lannett Company Inc	4.85	$ 340.579 Millions	$ 70.200 Millions

Date modified: 2026-09-08T15:10:42+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.